Fund shareholders of Arcus Biosciences Inc
ISIN US03969F1093 · United States
- Fund shareholders
- 245
- Of which ETFs
- 60 185 other funds
- Value held
- ≈ 774.4M $ 768.5M $ · 5M €
- Share of capital
- 26.9 % of 127.3M shares on Jul 30, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 1,965 | 42.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| THRIVENT AGGRESSIVE ALLOCATION PORTFOLIO Thrivent Series Fund, Inc. | 1,953 | 42.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PD Small-Cap Value Index Portfolio PACIFIC SELECT FUND | 1,888 | 40.8K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 1,861 | 40.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) 1500 Value Tilt ETF SPDR SERIES TRUST | 1,767 | 38.2K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| BlackRock Advantage SMID Cap V.I. Fund BlackRock Variable Series Funds, Inc. | 1,540 | 33.3K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| THRIVENT MODERATE ALLOCATION FUND Thrivent Mutual Funds | 1,491 | 38K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Nationwide Fundamental All Cap Equity Portfolio Nationwide Mutual Funds | 1,434 | 36.6K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Federated Hermes Global Allocation Fund Federated Hermes Global Allocation Fund | 1,410 | 28.7K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| THRIVENT GLOBAL STOCK FUND Thrivent Mutual Funds | 1,341 | 34.2K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 | 1,321 | 28.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| THRIVENT MODERATELY CONSERVATIVE ALLOCATION PORTFOLIO Thrivent Series Fund, Inc. | 1,262 | 27.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| THRIVENT GLOBAL STOCK PORTFOLIO Thrivent Series Fund, Inc. | 1,108 | 23.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP SMALLCAP GROWTH ProFunds | 1,064 | 23K $ | 0.15 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Small-Cap Equity Portfolio PACIFIC SELECT FUND | 964 | 20.8K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 945 | 24.1K $ | 0.04 % | 0.00 % | as of Apr 30, 2026 ↗ |
| ProShares Ultra SmallCap600 ProShares Trust | 935 | 19K $ | 0.08 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 799 | 17.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP SMALLCAP VALUE ProFunds | 791 | 17.1K $ | 0.09 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis U.S. Equity ETF American Century ETF Trust | 786 | 16K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 735 | 15.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SmallCap Value Fund II Principal Funds, Inc | 692 | 17.6K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 450 | 11.5K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) 1500 Momentum Tilt ETF SPDR SERIES TRUST | 412 | 8.9K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 391 | 8.4K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Innovator U.S. Small Cap Managed 10 Buffer ETF Innovator ETFs Trust | 378 | 9.6K $ | 0.13 % | 0.00 % | as of Apr 30, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 361 | 7.8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Wilshire 5000 Index Fund Wilshire Mutual Funds Inc | 347 | 7.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP GROWTH PROFUND ProFunds | 289 | 7.4K $ | 0.16 % | 0.00 % | as of Apr 30, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 281 | 6.1K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP VALUE PROFUND ProFunds | 215 | 5.5K $ | 0.09 % | 0.00 % | as of Apr 30, 2026 ↗ |
| THRIVENT MODERATELY CONSERVATIVE ALLOCATION FUND Thrivent Mutual Funds | 213 | 5.4K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 212 | 4.6K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 180 | 3.9K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 153 | 3.9K $ | 0.05 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Fidelity Flex Small Cap Focused Index Fund Fidelity Salem Street Trust | 137 | 3.5K $ | 0.02 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 108 | 2.3K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 81 | 1.6K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 77 | 1.7K $ | 0.05 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis Total Equity Markets ETF American Century ETF Trust | 66 | 1.3K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| E*TRADE No Fee Total Market Index Fund E Trade Trust | 46 | 1.2K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 23 | 468.5 $ | 0.04 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 21 | 453.6 $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| MERCHFONDO, FI ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. | 4.7M € | 2.68 % | as of Dec 31, 2025 ↗ | ||
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 304.2K € | 0.37 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| MERCHFONDO, FI ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. | 2.68 % | as of Dec 31, 2025 ↗ |
| iShares Genomics Immunology and Healthcare ETF iShares Trust | 2.12 % | as of Apr 30, 2026 ↗ |
| Nomura Healthcare Fund Delaware Group Equity Funds IV | 1.23 % | as of Mar 31, 2026 ↗ |
| Invesco S&P SmallCap Health Care ETF Invesco Exchange-Traded Fund Trust II | 1.04 % | as of Feb 28, 2026 ↗ |
| Invesco Dorsey Wright Healthcare Momentum ETF Invesco Exchange-Traded Fund Trust | 0.94 % | as of Apr 30, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 0.88 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 0.63 % | as of Mar 31, 2026 ↗ |
| PROFUND VP BIOTECHNOLOGY ProFunds | 0.61 % | as of Mar 31, 2026 ↗ |
| Direxion Daily S&P Biotech Bull 3X Shares Direxion Shares ETF Trust | 0.61 % | as of Apr 30, 2026 ↗ |
| Tema Oncology ETF Tema ETF Trust | 0.59 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 243 | +2 | 34,270,842 | +1.2 % |
| 2026Q1 | 241 | +14 | 33,864,776 | +37.0 % |
| 2025Q4 | 227 | +14 | 24,720,855 | -2.0 % |
| 2025Q3 | 213 | -3 | 25,237,140 | -5.6 % |
| 2025Q2 | 216 | +4 | 26,735,637 | +14.0 % |
| 2025Q1 | 212 | -9 | 23,459,147 | -4.4 % |
| 2024Q4 | 221 | -6 | 24,526,999 | +2.3 % |
| 2024Q3 | 227 | +1 | 23,967,017 | -10.0 % |
| 2024Q2 | 226 | -13 | 26,625,469 | +0.4 % |
| 2024Q1 | 239 | -15 | 26,527,456 | -1.9 % |
| 2023Q4 | 254 | 27,040,148 |
Institutional managers
201 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| GILEAD SCIENCES, INC. | 31,424,760 | 678.8M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 15,226,475 | 328.9M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 6,089,516 | 131.5M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 5,412,901 | 116.9M $ | as of Mar 31, 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,030,993 | 108.7M $ | as of Mar 31, 2026 |
| Woodline Partners LP | 3,777,798 | 81.6M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 3,761,437 | 81.2M $ | as of Mar 31, 2026 |
| Siren, L.L.C. | 3,007,077 | 65M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 2,252,367 | 48.7M $ | as of Mar 31, 2026 |
| Fisher Asset Management, LLC | 2,190,404 | 47.3M $ | as of Mar 31, 2026 |
| SAMLYN CAPITAL, LLC | 1,908,412 | 41.2M $ | as of Mar 31, 2026 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 1,654,754 | 35.7M $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 1,426,223 | 30.8M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 1,329,935 | 28.7M $ | as of Mar 31, 2026 |
| Parkman Healthcare Partners LLC | 1,207,274 | 26.1M $ | as of Mar 31, 2026 |
| Logos Global Management LP | 1,200,000 | 25.9M $ | as of Mar 31, 2026 |
| FMR LLC | 1,165,252 | 25.2M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1,113,526 | 24.1M $ | as of Mar 31, 2026 |
| Trails Edge Capital Partners, LP | 1,047,935 | 22.6M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 999,786 | 21.6M $ | as of Mar 31, 2026 |
| Sofinnova Investments, Inc. | 923,086 | 19.9M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 903,638 | 19.5M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 840,305 | 18.2M $ | as of Mar 31, 2026 |
| Invesco Ltd. | 820,820 | 17.7M $ | as of Mar 31, 2026 |
| Candriam S.C.A. | 790,613 | 17.1M $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Fund shareholders of Arcus Biosciences Inc". https://titelia.com/en/stocks/arcus-biosciences-inc-US03969F1093